bpc 157 fda warning not approved bpc-157 news FDA intends to exempt certain unclassified medical devices from premarket notification A closer look at the
Description
Current Pharmaceutical Design, 19(1), 7683

Yes, in some cases
According to the NICE Clinical Knowledge Summary (CKS) and the British National Formulary (BNF) , the standard treatment for B12 deficiency without neurological symptoms involves: Hydroxocobalamin 1 mg intramuscularly three times weekly for two weeks Followed by maintenance doses of 1 mg every three months For patients with neurological symptoms (such as paraesthesia, numbness, cognitive changes, or gait disturbances), more intensive treatment is required: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs Followed by 1 mg every two months for maintenance Pernicious anaemia , an autoimmune condition where the body cannot produce intrinsic factor, requires lifelong treatment
I do need to test my blood sugar anymore so did not bother to refill script
The consistency of the source is what makes the protocols results predictable over a 3-month cycle
